Company intelligence
IP Group plc
Visionary ventures
About IP Group plc
IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science and technology investor, we develop and support some of the world’s most exciting businesses in healthtech, deeptech, and cleantech. Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
Verified activity
Signals from IP Group plc
3 published signals
Strategy & Corporate Development
IP Group plc, together with Parkwalk, has built one of the UK's leading platforms for backing science and innovation over the past 25 years.
Reported by IP Group plc
Capital & Finance
IP Group plc received a £52.6m commitment from the National Wealth Fund, supported by the Korea Development Bank and Honda Xcelerator Ventures.
Reported by IP Group plc
Partnerships
IP Group plc has built deep partnerships with leading research institutions including the University of Oxford, the University of Cambridge, and Imperial College London over the past 25 years.
Reported by IP Group plc